Cancer of the cervix: prospects for immunological control

scientific article published on April 1, 1991

Cancer of the cervix: prospects for immunological control is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P953full work available at URLhttps://europepmc.org/articles/PMC2002301
https://europepmc.org/articles/PMC2002301?pdf=render
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1849733/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1849733/pdf/?tool=EBI
P932PMC publication ID2002301
P698PubMed publication ID1849733

P50authorBenny ChainQ56942468
P2093author name stringD. H. Davies
G. A. McIndoe
P2860cites workIdentification of the human papilloma virus-1a E4 gene productsQ24531494
ASSOCIATION BETWEEN ANORECTAL DYSPLASIA, HUMAN PAPILLOMAVIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL MENQ29306698
Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitroQ34566092
Subpopulations of Langerhans' cells in cervical neoplasiaQ70164900
Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytesQ70385929
Keratinocyte-derived T-cell growth factor: a T-cell growth factor functionally distinct from interleukin 2Q35611831
Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasiaQ35703028
Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allograftsQ35707583
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cellsQ36354420
Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).Q36354811
Genital condylomas in immunosuppressed women: a therapeutic challengeQ36424552
Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasiaQ36473470
Antibody-mediated neutralization in vivo of infectious papillomavirusesQ36809093
Laboratory production in vivo of infectious human papillomavirus type 11Q36884907
Histological and cytological evidence of viral infection and human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and normal tissue in the west of Scotland: evaluation of treatment policyQ36894600
Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera.Q36918393
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virusQ37259469
Multiple peptide synthesis (Pepscan method) for the systematic analysis of B- and T-cell epitopes: Application to parasite proteinsQ37897434
Human papillomaviruses and carcinomasQ38313900
The scid-hu mouse: current status and potential applicationsQ38709049
Immunobiology of human papillomavirus infectionQ39504444
Decreased T Cell Levels in Patients With WartsQ40670526
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationQ41561486
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination.Q41734503
Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading framesQ42614983
Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiencies and neoplasmsQ43470732
Detection of papillomavirus common antigens in lesions of skin and mucosaQ43479518
Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' regionQ44810055
Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopesQ45046745
Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinantQ45841399
Cell-mediated Immunity in Wart InfectionQ46645185
Monoclonal antibodies to genus- and type-specific papillomavirus structural antigens.Q52489682
Viral infections in renal allograft recipients treated with long-term immunosuppressionQ55603128
Gynecologic malignancies in immunosuppressed organ homograft recipientsQ66894009
Cell-mediated immune responses in patients with wartsQ67351684
Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1Q67654383
Antigen presentation by keratinocytes induces tolerance in human T cellsQ68358537
Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytesQ69000708
Keratinocytes produce a lymphocyte inhibitory factor which is partially reversible by an antibody to transforming growth factor-betaQ69068249
Identification of papillomaviral DNA sequences in hairless mouse tumours induced by ultraviolet irradiationQ69350589
The role of anal/genital warts in HIV infectionQ69450644
Tuberculin sensitivity in BCG-vaccinated children with common wartsQ70023158
Feline leukemia vaccine: efficacy, contents and probable mechanismQ70136300
Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reactionQ70141681
Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndromeQ70149899
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
P304page(s)239-251
P577publication date1991-04-01
P1433published inInternational Journal of Experimental PathologyQ15750807
P1476titleCancer of the cervix: prospects for immunological control
P478volume72

Reverse relations

Q72362056Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motifcites workP2860

Search more.